Ketamine Therapy | Delray Beach | NeuPath Mind Wellness

Online Ketamine vs. In-Person Ketamine: Why Clinic-Based Care Matters

Over the last few years, a new category of mental health service has emerged: online ketamine therapy. Companies like Mindbloom, Joyous, and others now offer ketamine treatment that can be prescribed remotely and taken at home, without a clinic visit, without medical supervision during the session, and without the oversight of a psychiatrist who knows your full history. For patients who have been struggling with depression and are looking for any path forward, the appeal is understandable. It is accessible, relatively affordable, and does not require you to leave your house. But the convenience comes with trade-offs that are worth understanding clearly before you make a decision. This post lays out exactly how online and in-person ketamine differ, where each approach has merit, and why for most patients dealing with serious depression, clinic-based care at a practice like NeuPath Mind Wellness produces meaningfully better outcomes. What Online Ketamine Actually Is Online ketamine services operate through a telehealth model. A patient completes an intake form and a brief virtual consultation with a prescribing clinician, often a nurse practitioner rather than a psychiatrist, and if approved receives a prescription for oral or sublingual ketamine lozenges that are mailed to their home. The patient then takes the ketamine at home, typically alone or with a friend or partner, without any clinical monitoring during the session. Some platforms provide a virtual companion or therapist to check in before and after, but the session itself is unsupervised. The ketamine used in these models is almost always oral or sublingual, meaning it is swallowed or dissolved under the tongue. This form of administration has significantly lower bioavailability than intravenous ketamine, meaning a much smaller proportion of the drug actually reaches the brain. The dissociative experience is milder, the therapeutic effect is less predictable, and the dosing is less precise. What In-Person Ketamine at NeuPath Looks Like At NeuPath Mind Wellness, ketamine therapy is administered intravenously under direct medical supervision in a calm, private clinical environment. IV ketamine delivers the drug directly into the bloodstream at a precisely controlled rate, producing consistent plasma concentrations and a predictable, clinically meaningful therapeutic effect. The session is monitored throughout by trained clinical staff who track your vital signs, adjust the infusion rate as needed, and are present for the entirety of the experience. Your treatment at NeuPath is overseen by a psychiatrist who knows your full history, your diagnosis, your medication background, and your treatment goals. Dosing decisions are made by that psychiatrist based on your individual response, not by a remote prescriber who spent fifteen minutes reviewing your intake form. Before your first infusion, you have a comprehensive psychiatric evaluation. After each session, your response is assessed and your treatment plan is adjusted accordingly. The ketamine does not exist in isolation from the rest of your care. The Key Differences Bioavailability and Therapeutic Effect This is the most clinically significant difference between the two models. IV ketamine has near-complete bioavailability. When delivered intravenously, essentially all of the drug reaches systemic circulation and crosses the blood-brain barrier at the intended concentration. The therapeutic effect is consistent, predictable, and well-documented across decades of clinical research. Oral and sublingual ketamine have bioavailability of approximately 20 to 30 percent. The majority of the drug is broken down in the digestive tract and liver before it reaches the brain. What arrives at the target site is a fraction of the administered dose, at concentrations that are harder to predict and control. This difference matters clinically. The robust antidepressant effects documented in ketamine research are based almost entirely on intravenous administration. Extrapolating those results to oral formulations requires assumptions that the evidence does not yet fully support. Medical Supervision and Safety Ketamine is a dissociative anesthetic. During an infusion, patients experience altered states of perception, changes in sense of time and space, and in some cases intense emotional or psychological experiences. These effects are transient and resolve after the session, but they require clinical oversight. At NeuPath, a trained clinician is present throughout every infusion. Vital signs are monitored continuously. If a patient experiences cardiovascular changes, significant distress, or an unexpected reaction, the clinical team responds immediately. Taking ketamine at home alone removes that safety net entirely. The risk is not theoretical. Ketamine affects blood pressure and heart rate, can cause nausea and vomiting in some patients, and produces psychological experiences that can be disorienting or distressing without appropriate support. Unsupervised use in a home environment introduces risks that supervised clinical administration does not. Psychiatric Oversight Perhaps the most underappreciated difference between online and in-person ketamine is the quality of the clinical relationship overseeing the treatment. Online ketamine platforms are primarily prescription services. The clinical relationship is thin by design. A brief telehealth consultation, often with a non-psychiatrist prescriber, is not equivalent to a comprehensive psychiatric evaluation with a clinician who understands the full complexity of your depression, your comorbidities, your medication history, and your treatment goals. At NeuPath, your ketamine treatment is embedded within a broader psychiatric care relationship. Your psychiatrist monitors your response over the course of treatment, identifies when a different approach might serve you better, and coordinates your ketamine care with any other treatments you are receiving, including TMS, Spravato, or GeneSight-informed medication management. That coordination is not possible in a model where the prescriber met you once on a video call. Integration With Other Treatments For many patients, ketamine works best as part of a broader treatment strategy rather than as a standalone intervention. The neuroplastic window that ketamine opens, the period immediately following an infusion when the brain is particularly receptive to new learning and connection, is an opportunity that can be amplified by therapy, by TMS, or by other supportive interventions. At NeuPath, we can combine ketamine with TMS therapy, Spravato, and psychiatric medication management in a coordinated plan. Online ketamine platforms offer none of this. The ketamine is the product, and the clinical relationship ends there. Where Online Ketamine Has a Role This post is not

Is GeneSight Testing Covered by Insurance?

One of the first questions patients ask when they learn about GeneSight genetic testing is whether their insurance will cover it. It is the right question to ask, and the answer is more favorable than most people expect. GeneSight testing is covered by many insurance plans, including Medicare, for patients who meet clinical criteria. At NeuPath Mind Wellness, we verify your coverage before the test is ordered so there are no surprises and no unexpected bills. Here is everything you need to know about GeneSight insurance coverage, which plans cover it, what the requirements are, and what your options are if your plan does not cover it. Why Insurance Covers GeneSight GeneSight is not an experimental test. It is a clinically validated pharmacogenomic tool developed by Myriad Genetics, one of the leading genetic testing laboratories in the United States, with over a decade of peer-reviewed research supporting its clinical utility. Insurance companies cover GeneSight because the evidence demonstrates that pharmacogenomic-guided prescribing reduces the number of failed medication trials, lowers hospitalization rates, and produces better outcomes for patients with depression and other psychiatric conditions. From a payer perspective, a test that costs a few hundred dollars and reduces months of ineffective medication trials is a sound investment. The landmark GUIDED trial, a large randomized controlled study published in the Journal of Psychiatric Research, found that patients whose treatment was guided by GeneSight results experienced significantly greater symptom improvement and higher remission rates compared to patients receiving treatment as usual. This kind of evidence is what moves insurers to establish formal coverage policies. Which Insurance Plans Cover GeneSight? GeneSight is covered by a broad range of commercial insurance plans as well as Medicare. Plans that commonly cover GeneSight testing include: Coverage policies and criteria vary by plan and change periodically. The most reliable way to confirm your specific coverage is to contact our team at NeuPath and we will verify your benefits directly before the test is ordered. What Are the Typical Coverage Requirements? Most insurance plans that cover GeneSight require the following: A psychiatric diagnosis. Coverage is most consistently available for patients with a diagnosis of major depressive disorder, anxiety disorder, PTSD, OCD, or another psychiatric condition for which the test results would inform treatment decisions. A documented medication history. Insurers typically require evidence that the patient has tried at least one psychiatric medication. For patients who are starting treatment for the first time, some plans will cover GeneSight as a proactive tool, though criteria are more stringent in these cases. A treating psychiatrist or qualified provider. Coverage requires that the test is ordered by a licensed psychiatrist or qualified mental health provider as part of an active treatment relationship. At NeuPath, all GeneSight testing is ordered and interpreted by our psychiatric team, which satisfies this requirement. Medical necessity documentation. Your psychiatrist provides clinical documentation supporting the medical necessity of the test, typically including your diagnosis, medication history, and the clinical rationale for pharmacogenomic testing. Does Medicare Cover GeneSight? Yes. Medicare Part B covers GeneSight testing for patients with depression and other psychiatric conditions who meet clinical criteria. This is particularly significant for patients 65 and older, who often have complex medication histories and are at higher risk for drug-drug interactions that GeneSight can help identify. Medicare Advantage plans generally follow similar coverage guidelines, though the specific terms vary by plan. Our team verifies Medicare coverage and handles all necessary documentation for Medicare patients exactly as we do for commercial insurance patients. What If My Insurance Does Not Cover GeneSight? If your insurance plan does not cover GeneSight or your claim is denied, there are several options available. The Myriad Patient Assistance Program. Myriad Genetics, the laboratory that processes GeneSight tests, offers a robust patient assistance program for patients whose insurance does not cover the test. Under this program, patients who meet income eligibility criteria pay no more than $330 out of pocket, and many pay significantly less. Our team can walk you through the application process. Appeals. Insurance denials for GeneSight can often be successfully appealed, particularly when your psychiatrist provides a detailed clinical justification. Our team assists with the appeals process and can provide the documentation needed to support your case. Out-of-pocket testing. For patients who choose to pay out of pocket without going through the assistance program, the cost of GeneSight testing is significantly lower than the cumulative cost of multiple failed medication trials in terms of time, productivity, and quality of life. How NeuPath Handles the Insurance Process At NeuPath Mind Wellness, we manage the insurance verification and documentation process for GeneSight the same way we do for TMS and Spravato. You do not need to navigate this on your own. Here is how it works: Step 1: During your consultation, your psychiatrist determines that GeneSight testing is clinically appropriate for your situation. Step 2: Our team contacts your insurer to verify your GeneSight benefits and confirm whether prior authorization is required. Step 3: If prior authorization is needed, our team submits the necessary clinical documentation on your behalf. Step 4: Once coverage is confirmed, the test is ordered. A simple cheek swab is collected at our clinic, the sample is sent to Myriad’s laboratory, and results are returned within a few days. Step 5: Your psychiatrist reviews the results with you and integrates the findings into your treatment plan. You will know what your plan covers before the test is ordered. No surprises. GeneSight as Part of Your Broader Treatment Plan at NeuPath At NeuPath Mind Wellness, GeneSight testing does not exist in isolation. It is one component of a comprehensive psychiatric care model that includes medication management, TMS therapy, ketamine infusion therapy, Spravato, and ongoing psychiatric support. For patients who are also receiving TMS or ketamine at NeuPath, GeneSight results inform the medication component of their care in parallel, ensuring that every element of the treatment plan is working in the same direction. A patient receiving TMS who is simultaneously on a poorly matched

Why Antidepressants Stop Working and What to Do Next

You found a medication that helped. Maybe it took a few tries to get there, but eventually something worked. Your mood lifted, the weight of depression eased, and for a while you felt like yourself again. Then, gradually or suddenly, it stopped working. This experience has a name. Clinicians call it antidepressant tachyphylaxis, though patients more often describe it simply as their medication pooping out. It is more common than most people realize, affects a significant proportion of patients on long-term antidepressant therapy, and is one of the most frustrating experiences in psychiatric treatment because it raises a question that feels impossible to answer: if the thing that was working has stopped working, what do you do next? This post answers that question directly. Why Antidepressants Stop Working Before exploring what to do next, it helps to understand why this happens. There is no single explanation that applies to every patient, but the most well-supported mechanisms include the following. Neurobiological adaptation. The brain is constantly adjusting to its chemical environment. When an antidepressant increases serotonin availability in the synaptic cleft, the brain responds over time by downregulating serotonin receptors, reducing their number or sensitivity to compensate for the increased stimulation. Eventually this adaptation can offset the therapeutic effect of the medication, even at the same dose. Changes in your biology over time. Depression is not a static condition and neither is the biology underlying it. Hormonal shifts, aging, changes in inflammation levels, metabolic changes, and the natural progression of the illness itself can all alter how your brain responds to a medication that previously worked well. Genetic factors you did not know about. Your liver enzymes, particularly the cytochrome P450 family, play a major role in how quickly your body clears medications from your system. These enzyme activity levels can shift with age, with other medications you start taking, or with changes in diet. A medication that was previously metabolized at an ideal rate may begin clearing too quickly or too slowly over time, taking it out of its therapeutic window. Stress and life circumstances. Major stressors, trauma, grief, relationship changes, and other life events can overwhelm the capacity of a medication that was previously sufficient. The antidepressant has not changed but the load it is being asked to carry has increased beyond what it can manage. The medication was never fully working. Sometimes what felt like a response was a partial improvement or a placebo component that has faded. This is not a moral failing. It is a reflection of how difficult it is to distinguish between a genuine pharmacological response and the natural variability of depression over time. What Not to Do Before covering what works, it is worth addressing the most common unhelpful responses to antidepressant failure, because they are tempting and understandable but rarely productive. Do not simply increase the dose without guidance. Dose escalation is sometimes clinically appropriate but it is not always the answer and can increase side effects without improving efficacy if the underlying issue is adaptation or a genetic mismatch rather than underdosing. Do not stop abruptly. Discontinuing antidepressants suddenly can cause discontinuation syndrome, a cluster of symptoms including dizziness, nausea, flu-like feelings, and mood instability that is often mistaken for relapse. Always taper under psychiatric supervision. Do not assume you are out of options. This is the most important point in this section and arguably in this entire post. A medication stopping working is not evidence that your depression is untreatable. It is evidence that your current approach needs to change. What to Do Next: Your Options Option 1: Optimize Your Current Medication Before switching medications entirely, there are several adjustments worth exploring with your psychiatrist. A dose adjustment, either up or down, may restore efficacy. Timing changes, such as shifting from morning to evening dosing, can affect how the drug is metabolized. Adding a short-term augmentation agent, a second medication that works alongside the antidepressant, is a well-established strategy for restoring response. Common augmentation options include lithium, atypical antipsychotics like aripiprazole or quetiapine, or buspirone. None of these adjustments should be made without psychiatric oversight, but they are often the first reasonable step before moving to a full medication switch. Option 2: Switch to a Different Antidepressant If optimization does not restore response, switching medications is the next logical step. This is where the trial-and-error problem becomes most acute. Without additional information, the choice of which medication to try next is largely educated guesswork. This is exactly the situation GeneSight genetic testing is designed to improve. Option 3: GeneSight Genetic Testing GeneSight analyzes your DNA to identify how your body metabolizes psychiatric medications and how your brain is likely to respond to them. The test produces a color-coded report that categorizes every major antidepressant as likely to work well, likely to require caution, or likely to carry elevated risk based on your specific genetic profile. For patients cycling through failed medication trials, GeneSight can reveal whether genetic factors are contributing to the pattern. A patient who is an ultra-rapid metabolizer of CYP2D6-dependent medications, for example, may have been clearing SSRIs so quickly that they never reached therapeutic concentration, explaining a long history of apparent non-response to multiple drugs in the same class. GeneSight does not guarantee that the next medication will work. But it replaces guesswork with data, and for patients who have already spent months or years on medications that were never a good genetic match, that shift in approach can be genuinely transformative. GeneSight testing is available at NeuPath Mind Wellness across all three of our South Florida locations and is covered by many insurance plans including Medicare. Option 4: TMS Therapy If medication optimization and switching have not produced adequate relief, Transcranial Magnetic Stimulation is one of the most well-supported next steps available. TMS is FDA-approved for treatment-resistant depression and works through an entirely different mechanism than antidepressants. Rather than altering brain chemistry through the bloodstream, TMS uses focused magnetic pulses to directly stimulate the neural

Discover a new path to Mental Health and Wellness

Discover a new path to Mental Health and Wellness

ELEVATED MENTAL HEALTH CARE IN DELRAY BEACH

OUR SERVICES

KETAMINE TREATMENT

SPRAVATO TREATMENT

INTEGRATIVE MENTAL HEALTH AND PSYCHIATRIC SERVICES

TMS THERAPY

WELLNESS THAT WORKS

THE NEUPATH MIND WELLNESS DIFFERENCE

iNSURANCE aCCEPTED

RESOURCES AND NEWS

SCHEDULE A CONSULTATION